Core signs and symptoms of diabetic gastroparesis (DG) are nausea, abdominal pain, post-prandial fullness, bloating, vomiting, and early satiety (a feeling of fullness after eating just a few bites). These symptoms can be debilitating and, when uncontrolled, have a significant negative impact on patient quality of life. DG complicates blood glucose management for patients due to carbohydrates being delivered to and therefore absorbed from the small intestine at unpredictable times. As a result, diabetic patients with DG often have poorly controlled diabetes, frequently with alternating hypo- and hyperglycemia, especially if treated with insulin.
Meridian is now conducting a clinical study for an investigational DG medication.
- Must be age 18+
- Must have Type 1 or 2 diabetes
- Must have experienced nausea, abdominal pain, bloating, vomiting, early satiety, etc. (symptoms of DG) for the past 3 months
- Must have vomited at least 2 times in the past 2 weeks
- May receive compensation for time and travel
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.
You can also talk to a Meridian enrollment specialist about this study by calling (912) 623-2240.
Meridian Clinical Research
1201 Seven Locks Road, Suite 111
Rockville, MD 20854
Sign up for more information...
About Meridian Clinical Research
Founded in 1999, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services.
Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For almost 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.